Human decorin regulates proliferation and migration of human lung cancer A549 cells

Chinese Medical Journal

Volumn 126, Issue 24, 2013, Pages 4736-4741

  Liang, Shuo ^a   Xu, Jin Fu ^a   Cao, Wei Jun ^a   Li, Hui Ping ^a   Hu, Cheng Ping ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Decorin; Lentivirus; Lung cancer; Proliferation

Indexed keywords

CYCLIN D1; DECORIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LENTIVIRUS VECTOR; MESSENGER RNA; PROTEIN P21; PROTEIN P53; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LUNG CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; TUMOR INVASION; WESTERN BLOTTING;

CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; DECORIN; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 84890385742     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20130207     Document Type: Article

References (36)

1. Bilello KS, Murin S, Matthay RA. Epidemiology, etiology, and prevention of lung cancer. Clin Chest Med 2002; 23: 1-25.
2. Alavanja MC. Biologic damage resulting from exposure to tobacco smoke and from radon: implication for preventive interventions. Oncogene 2002; 21: 7365-7375.
3. Zhang P, Gao WY, Turner S, Ducatman BS. Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro. Molecular cancer 2003; 2: 1.
4. Midthun DE, Jett JR. Chemotherapy for advanced lung cancer. When to expect are sponse. Postgrad Med 1997; 101: 187-188, 191-182, 194 passim.
5. Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis inA549 lung cancer cells. Carcinogenesis 2004; 25: 647-659.
6. Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA, et al. A novel antisense oligonucleotide targeting surviving expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 2000; 60: 2805-2809.
7. Tralhao JG, Schaefer L, Micegova M, Evaristo C, Schonherr E, Kayal S, et al. In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. Faseb J 2003; 17: 464-466.
8. Iozzo RV. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 1999; 27: 18843-18846.
9. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281-284.
10. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, et al. Natural inhibitor of transforming growth factor-beta protects against carring in experimental kidney disease. Nature 1992; 360: 361-364.
11. Santra M, Reed CC, Iozzo RV. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J Biol Chem 2002; 277: 35671-35681.
12. Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, Iozzo RV. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 1998; 101: 406-412.
13. Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 1999; 274: 4489-4492.
14. Csordas G, Santra M, Reed CC, Eichstetter I, McQuillan DJ, Gross D, et al. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem 2000; 275: 32879-32887.
15. Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest 1997; 100: 149-157.
16. De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 1996; 271: 18961-18965.
17. Xaus J, Comalada M, Cardo M, Valledor AF, Celada A. Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). Blood 2001; 98: 2124-2133.
18. Goldoni S, Iozzo RV. Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer 2008; 123: 2473-2479.
19. McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002; 8: 1127-1138.
20. Liang S, Hu C, He B, Zhou D, Xia Y. Effects and mechanism of decorin on the proliferation of A549 lung adenocarcinoma cells in vitro. Chin J Lung Cancer (Chin) 2007; 10: 9-13.
21. Simmons JG, Pucilowska JB, Keku TO, Lund PK. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol. 2002; 283: G809-G818.
22. Yan Z, Kim GY, Deng X, Friedman E. Transforming growth factor beta 1induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. J Biol Chem 2002; 277: 9870-9879.
23. Damstrup L, Rude Voldborg B, Spang-Thomsen M, Brunner N, Skovgaard Poulsen H. In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor. Br J Cancer 1998; 78: 631-640.
24. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993; 7: 812-821.
25. Cayrol C, Knibiehler M, Ducommun B. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 1998; 16: 311-320.
26. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A 1995; 92: 8493-8497.
27. Gargiullo P, Wingo PA, Coates RJ, Thompson TD; Center for Disease Control and Prevention (CDC). Recent trends in mortality rates for four major cancers, by sex and race/ethnicity--United States, 1990-1998. MMWR Morb Mortal Wkly Rep 2002; 51: 49-53.
28. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, et al. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996; 86: 531-542.
29. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR, et al. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003; 112: 1116-1124.
30. Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, et al. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 2004; 21: 491-501.
31. Iozzo RV, Chakrani F, Perrotti D, McQuillan DJ, Skorski T, Calabretta B, et al. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci U S A 1999; 96: 3092-3097.
32. Stander M, Naumann U, Wick W, Weller M. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 1999; 296: 221-227.
33. Reed CC, Waterhouse A, Kirby S, Kay P, Owens RT, McQuillan DJ, et al. Decorin prevents metastatic spreading of breast cancer. Oncogene 2005; 24: 1104-1110.
34. Wu Y, Xiao T, Li M, Zhang Y, Gao Y, Sun K. Decorin protein is down-regulated in non-small cell lung cancer tissue and significantly associated with histological type. Chin J Lung Cancer (Chin) 2011; 14: 848-852.
35. Kornmann M, Tangvoranuntakul P, Korc M. TGF-beta-1 up-regulates cyclinD1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor. Int J Cancer 1999; 83: 247-254.
36. Buraschi S, Pal N, Tyler-Rubinstein N, Owens RT, Neill T, Iozzo RV. Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels. J Biol Chem 2010; 285: 42075-42085.